Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events

[News]

A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the incidence of distant metastases in postmenopausal women...

More... (http://www.medicalnewstoday.com/releases/238850.php)